Navigation Links
PRA International Participating in Pharmacoeconomics and Outcomes Research Conference
Date:5/15/2009

RALEIGH, N.C., May 15 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, announces it will exhibit at the annual meeting for the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), May 18-20 in Orlando, Florida. Experts from PRA's Late Phase Services group will be present in Booth 19 at ISPOR to discuss PRA's capabilities.

PRA's Late Phase Services group supports global and regional Post-Approval studies. With many years experience managing late phase studies ranging in size from 60 to 18,000 patients in over 40 countries, our international management team leads a truly global late phase team with centralized locations in Horsham, PA and Mannheim, Germany. PRA supports our Late Phase Services operational team with industry-leading strategic, scientific, medical and epidemiological experts.

To coordinate a meeting with PRA at ISPOR or for information on our upcoming audio conference, Blending REMS Science & Operational Execution, please contact David Fineza via email at finezadavid@praintl.com .

About PRA International

PRA International is a global Clinical Research Organization providing services through all phases of clinical development. We perform studies in all therapeutic areas, with specialization in Oncology, Neurosciences, Respiratory/Allergy, Cardiovascular and Infectious Diseases. PRA has supported over 2,100 clinical trials through its 35 global offices. PRA's therapeutic expertise, global reach and project experience, combined with extensive local knowledge and our differentiating PERSONAL ELEMENT enable our project teams to deliver consistent and on time performance for our clients. This unique PRA philosophy - THE PERSONAL ELEMENT - recognizes that true client service comes only from trained, empowered and dedicated employees who are encouraged to use innovation and their personal commitment to accelerate the development lifecycle.

To learn more about PRA International, please visit http://www.prainternational.com, email endpoints@praintl.com or call our Global Headquarters at +1 (919) 786-8200.


'/>"/>
SOURCE PRA International
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Spherix to Exhibit at the BIO 2009 International Convention
2. BioMS Medical to participate in panel session at Bio International Convention 2009
3. Kibow Biotech, Inc. to Present at BIO 2009 International Convention: Innovations to Heal, Fuel, and Feed the World
4. PAREXEL Consulting Experts To Present Insights Into Achieving Regulatory Approval at the 2009 BIO International Convention
5. Cell Therapeutics, Inc. (CTI) to Present at 2009 BIO International Convention
6. Boston Scientific to Donate Cardiac Rhythm Management Devices to Heartbeat International for Implantation in Needy Patients
7. Poniard Pharmaceuticals to Present at the 2009 BIO International Convention
8. BlueFire Ethanol To Present at BIO 2009 International Convention
9. GeoVax to Exhibit at the 2009 BIO International Convention
10. Yongye Biotechnology International Raises $ 9.0 Million In Private Placement, Raises Guidance
11. DATATRAK International, Inc. Forms Strategic Partnership with Inclinix, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... Ginkgo Bioworks, the organism company, announced ... the synthesis and assembly of DNA. The acquisition ... synthetic DNA into Ginkgo,s automated organism engineering foundries, ... of new organism designs for application across a ... founded to significantly increase the world,s capacity to ...
(Date:1/19/2017)... and HOUSTON , ... ("NX Prenatal") today announced the formation of its ... leading clinicians and industry veterans who enhance the ... as it accelerates development of its novel prenatal ... provide medical, clinical and strategic guidance for the ...
(Date:1/19/2017)... and GAITHERSBURG, Md. , Jan. ... and Altimmune, Inc., a privately-held immunotherapeutics company targeting ... definitive agreement for the merger of PharmAthene and ... include Novartis Venture Fund, HealthCap, Truffle Capital and ... fully-integrated and diversified immunotherapeutics company with four clinical ...
(Date:1/19/2017)... ... ... FireflySci Inc. is a go-getter type of company that continues to grow ... main factors. The first is the amazing customer service that the FireflySci staff ... around the world. , 2016 was a tremendous sales year for FFS and much ...
Breaking Biology Technology:
(Date:1/6/2017)... 5, 2017  Delta ID Inc., a leader in ... for automotive at CES® 2017. Delta ID has collaborated ... demonstrate the use of iris scanning as a secure, ... driver in a car, and as a way to ... Delta ID and Gentex will demonstrate (booth ...
(Date:12/22/2016)... Calif. , Dec. 20, 2016  As part of ... 23andMe, the leading personal genetics company, recently released its latest ... . The book focuses on the topics of inheritance ... Generation Science Standards (NGSS) taught in elementary school classrooms in ... in a series by illustrator Ariana Killoran , whose ...
(Date:12/19/2016)... BARCELONA , España y TORONTO , 19 ... fusión con Northern Biologics Inc. que permitirá el desarrollo acelerado de ... ensayos clínicos en varios tipos de tumor en 2017, con múltiples ... ... de su clase con objetivo en el factor inhibidor de leucemia ...
Breaking Biology News(10 mins):